Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF GLOBAL POLYISOPRENE (PI) SURGICAL GLOVES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE GLOBAL POLYISOPRENE (PI) SURGICAL GLOVES MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 GLOBAL POLYISOPRENE (PI) SURGICAL GLOVES MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PORTER’S 5 FORCES
5.2 PESTEL ANALYSIS
5.3 CONSUMER BEHAVIOR ANALYSIS
5.4 FACTORS INFLUENCING BUYING DECISION
5.5 PRODUCT ADOPTION SCENARIO
5.6 POLYISOPRENE LATEX, BY MANUFACTURER
5.6.1 ANNUAL CAPACITY SUBJECT TO DATA AVAILABILITY
5.6.2 YOY SALES GROWTH
5.6.3 EXPANSION
5.6.4 PRICE OF PI LATEX
5.7 BUYERS’ OVERVIEW: LIST OF KEY PI SURGICAL GLOVES MANUFACTURERS
5.7.1 ESTIMATED ANNUAL CONSUMPTION
5.7.2 YOY CONSUMPTION GROWTH
5.7.3 PRICE OF PI LATEX PURCHASED
6 INDUSTRY INSIGHTS
7 REGULATORY FRAMWORK
7.1.1 PRODUCT CODES
7.1.2 CERTIFIED STANDARDS
7.1.3 SAFETY STANDARDS
7.1.3.1. MATERIAL HANDLING & STORAGE
7.1.3.2. TRANSPORT & PRECAUTIONS
7.1.3.3. HAZARD IDENTIFICATION
8 IMPACT OF COVID-19 PANDEMIC ON THE MARKET
8.1 PRICE IMPACT
8.2 IMPACT ON DEMAND
8.3 IMPACT ON SUPPLY CHAIN
8.4 STRATEGIC DECISION FOR MANUFACTURER/SERVICE PROVIDER
8.5 PRE AND POST COVID-19 IMPACT ON MARKET NEED OF POLYISOPRENE
8.5.1 AFTER COVID -19, THE GROWTH OF PI LATEX INCREASE OR NOT
8.6 CONCLUSION
9 GLOBAL POLYISOPRENE (PI) SURGICAL GLOVES MARKET, BY END USER
9.1 OVERVIEW
9.2 HOSPITALS
9.2.1 BY PRODUCT
9.2.1.1. EXAMINATION
9.2.1.2. SURGICAL
9.2.1.3. CHEMOTHERAPY
9.2.2 BY USAGE
9.2.2.1. DISPOSABLE
9.2.2.2. REUSABLE
9.2.3 BY FORM
9.2.3.1. POWDERED
9.2.3.2. POWDER-FREE
9.2.4 BY GLOVE SIZE
9.2.4.1. 5.5
9.2.4.2. 6
9.2.4.3. 6.5
9.2.4.4. 7
9.2.4.5. 7.5
9.2.4.6. 8
9.2.4.7. 8.5
9.2.4.8. 9
9.3 CLINICS
9.3.1 BY PRODUCT
9.3.1.1. EXAMINATION
9.3.1.2. SURGICAL
9.3.1.3. CHEMOTHERAPY
9.3.2 BY USAGE
9.3.2.1. DISPOSABLE
9.3.2.2. REUSABLE
9.3.3 BY FORM
9.3.3.1. POWDERED
9.3.3.2. POWDER-FREE
9.3.4 BY GLOVE SIZE
9.3.4.1. 5.5
9.3.4.2. 6
9.3.4.3. 6.5
9.3.4.4. 7
9.3.4.5. 7.5
9.3.4.6. 8
9.3.4.7. 8.5
9.3.4.8. 9
9.4 DIAGNOSTIC CENTERS
9.4.1 BY PRODUCT
9.4.1.1. EXAMINATION
9.4.1.2. SURGICAL
9.4.1.3. CHEMOTHERAPY
9.4.2 BY USAGE
9.4.2.1. DISPOSABLE
9.4.2.2. REUSABLE
9.4.3 BY FORM
9.4.3.1. POWDERED
9.4.3.2. POWDER-FREE
9.4.4 BY GLOVE SIZE
9.4.4.1. 5.5
9.4.4.2. 6
9.4.4.3. 6.5
9.4.4.4. 7
9.4.4.5. 7.5
9.4.4.6. 8
9.4.4.7. 8.5
9.4.4.8. 9
9.5 REHABILITATION CENTERS
9.5.1 BY PRODUCT
9.5.1.1. EXAMINATION
9.5.1.2. SURGICAL
9.5.1.3. CHEMOTHERAPY
9.5.2 BY USAGE
9.5.2.1. DISPOSABLE
9.5.2.2. REUSABLE
9.5.3 BY FORM
9.5.3.1. POWDERED
9.5.3.2. POWDER-FREE
9.5.4 BY GLOVE SIZE
9.5.4.1. 5.5
9.5.4.2. 6
9.5.4.3. 6.5
9.5.4.4. 7
9.5.4.5. 7.5
9.5.4.6. 8
9.5.4.7. 8.5
9.5.4.8. 9
9.6 AMUBLATORY SURGERY CENTERS
9.6.1 BY PRODUCT
9.6.1.1. EXAMINATION
9.6.1.2. SURGICAL
9.6.1.3. CHEMOTHERAPY
9.6.2 BY USAGE
9.6.2.1. DISPOSABLE
9.6.2.2. REUSABLE
9.6.3 BY FORM
9.6.3.1. POWDERED
9.6.3.2. POWDER-FREE
9.6.4 BY GLOVE SIZE
9.6.4.1. 5.5
9.6.4.2. 6
9.6.4.3. 6.5
9.6.4.4. 7
9.6.4.5. 7.5
9.6.4.6. 8
9.6.4.7. 8.5
9.6.4.8. 9
9.7 OTHERS
9.7.1 BY PRODUCT
9.7.1.1. EXAMINATION
9.7.1.2. SURGICAL
9.7.1.3. CHEMOTHERAPY
9.7.2 BY USAGE
9.7.2.1. DISPOSABLE
9.7.2.2. REUSABLE
9.7.3 BY FORM
9.7.3.1. POWDERED
9.7.3.2. POWDER-FREE
9.7.4 BY GLOVE SIZE
9.7.4.1. 5.5
9.7.4.2. 6
9.7.4.3. 6.5
9.7.4.4. 7
9.7.4.5. 7.5
9.7.4.6. 8
9.7.4.7. 8.5
9.7.4.8. 9
10 GLOBAL POLYISOPRENE (PI) SURGICAL GLOVES MARKET, BY PRODUCT TYPE
10.1 OVERVIEW
10.2 EXAMINATION
10.3 SURGICAL
10.4 CHEMOTHERAPY
11 GLOBAL POLYISOPRENE (PI) SURGICAL GLOVES MARKET, BY USAGE
11.1 OVERVIEW
11.2 DISPOSABLE GLOVES
11.3 REUSABLE GLOVES
12 GLOBAL POLYISOPRENE (PI) SURGICAL GLOVES MARKET, BY FORM
12.1 OVERVIEW
12.2 POWDERED
12.3 POWDER-FREE
13 GLOBAL POLYISOPRENE (PI) SURGICAL GLOVES MARKET, BY GLOVE SIZE
13.1 OVERVIEW
13.2 5.5
13.3 6
13.4 6.5
13.5 7
13.6 7.5
13.7 8
13.8 8.5
13.9 9
14 GLOBAL POLYISOPRENE (PI) SURGICAL GLOVES MARKET, BY DISTRIBUTION CHANNEL
14.1 OVERVIEW
14.2 DIRECT SELLING
14.3 MEDICAL STORE
14.4 ONLINE
14.4.1 THIRD PARTY-OWNED
14.4.2 COMPANY-OWNED
14.5 OTHERS
15 GLOBAL POLYISOPRENE (PI) SURGICAL GLOVES MARKET, BY REGION
15.1 GLOBAL POLYISOPRENE (PI) SURGICAL GLOVES MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
15.2 NORTH AMERICA
15.2.1 U.S.
15.2.2 CANADA
15.2.3 MEXICO
15.3 EUROPE
15.3.1 GERMANY
15.3.2 FRANCE
15.3.3 U.K.
15.3.4 HUNGARY
15.3.5 LITHUANIA
15.3.6 AUSTRIA
15.3.7 IRELAND
15.3.8 NORWAY
15.3.9 POLAND
15.3.10 ITALY
15.3.11 SPAIN
15.3.12 RUSSIA
15.3.13 TURKEY
15.3.14 NETHERLANDS
15.3.15 SWITZERLAND
15.3.16 REST OF EUROPE
15.4 ASIA-PACIFIC
15.4.1 JAPAN
15.4.2 CHINA
15.4.3 SOUTH KOREA
15.4.4 INDIA
15.4.5 AUSTRALIA
15.4.6 SINGAPORE
15.4.7 THAILAND
15.4.8 MALAYSIA
15.4.9 INDONESIA
15.4.10 PHILIPPINES
15.4.11 VIETNAM
15.4.12 REST OF ASIA-PACIFIC
15.5 SOUTH AMERICA
15.5.1 BRAZIL
15.5.2 ARGENTINA
15.5.3 PERU
15.5.4 REST OF SOUTH AMERICA
15.6 MIDDLE EAST AND AFRICA
15.6.1 SOUTH AFRICA
15.6.2 SAUDI ARABIA
15.6.3 UAE
15.6.4 EGYPT
15.6.5 ISRAEL
15.6.6 KUWAIT
15.6.7 REST OF MIDDLE EAST AND AFRICA
15.7 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
16 GLOBAL POLYISOPRENE (PI) SURGICAL GLOVES MARKET, COMPANY LANDSCAPE
16.1 COMPANY SHARE ANALYSIS: GLOBAL
16.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
16.3 COMPANY SHARE ANALYSIS: EUROPE
16.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
16.5 MERGERS & ACQUISITIONS
16.6 NEW PRODUCT DEVELOPMENT & APPROVALS
16.7 EXPANSIONS
16.8 REGULATORY CHANGES
16.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
17 GLOBAL POLYISOPRENE (PI) SURGICAL GLOVES MARKET, SWOT AND DBMR ANALYSIS
18 GLOBAL POLYISOPRENE (PI) SURGICAL GLOVES MARKET, COMPANY PROFILE
18.1 ANSELL LTD
18.1.1 COMPANY OVERVIEW
18.1.2 GEOGRAPHIC PRESENCE
18.1.3 REVENUE ANALYSIS
18.1.4 PRODUCT PORTFOLIO
18.1.5 RECENT DEVELOPEMENTS
18.2 CARDINAL HEALTH
18.2.1 COMPANY OVERVIEW
18.2.2 GEOGRAPHIC PRESENCE
18.2.3 REVENUE ANALYSIS
18.2.4 PRODUCT PORTFOLIO
18.2.5 RECENT DEVELOPEMENTS
18.3 MEDLINE INDUSTRIES, INC.
18.3.1 COMPANY OVERVIEW
18.3.2 GEOGRAPHIC PRESENCE
18.3.3 REVENUE ANALYSIS
18.3.4 PRODUCT PORTFOLIO
18.3.5 RECENT DEVELOPEMENTS
18.4 MOLNLYCKE HEALTH CARE AB
18.4.1 COMPANY OVERVIEW
18.4.2 GEOGRAPHIC PRESENCE
18.4.3 REVENUE ANALYSIS
18.4.4 PRODUCT PORTFOLIO
18.4.5 RECENT DEVELOPEMENTS
18.5 WRP ASIA PACIFIC SDN BHD.
18.5.1 COMPANY OVERVIEW
18.5.2 GEOGRAPHIC PRESENCE
18.5.3 REVENUE ANALYSIS
18.5.4 PRODUCT PORTFOLIO
18.5.5 RECENT DEVELOPEMENTS
18.6 SEMPERMED USA, INC.
18.6.1 COMPANY OVERVIEW
18.6.2 GEOGRAPHIC PRESENCE
18.6.3 REVENUE ANALYSIS
18.6.4 PRODUCT PORTFOLIO
18.6.5 RECENT DEVELOPEMENTS
18.7 MCKESSON
18.7.1 COMPANY OVERVIEW
18.7.2 GEOGRAPHIC PRESENCE
18.7.3 REVENUE ANALYSIS
18.7.4 PRODUCT PORTFOLIO
18.7.5 RECENT DEVELOPEMENTS
18.8 BUDEV BV
18.8.1 COMPANY OVERVIEW
18.8.2 GEOGRAPHIC PRESENCE
18.8.3 REVENUE ANALYSIS
18.8.4 PRODUCT PORTFOLIO
18.8.5 RECENT DEVELOPEMENTS
18.9 INNOVATIVE HEALTHCARE CORPORATION
18.9.1 COMPANY OVERVIEW
18.9.2 GEOGRAPHIC PRESENCE
18.9.3 REVENUE ANALYSIS
18.9.4 PRODUCT PORTFOLIO
18.9.5 RECENT DEVELOPEMENTS
18.1 LIFELINK, INC.
18.10.1 COMPANY OVERVIEW
18.10.2 GEOGRAPHIC PRESENCE
18.10.3 REVENUE ANALYSIS
18.10.4 PRODUCT PORTFOLIO
18.10.5 RECENT DEVELOPEMENTS
18.11 XIANTAO LINGYANG PLASTIC CO. LTD.
18.11.1 COMPANY OVERVIEW
18.11.2 GEOGRAPHIC PRESENCE
18.11.3 REVENUE ANALYSIS
18.11.4 PRODUCT PORTFOLIO
18.11.5 RECENT DEVELOPEMENTS
18.12 HARTALEGA HOLDINGS BERHAD
18.12.1 COMPANY OVERVIEW
18.12.2 GEOGRAPHIC PRESENCE
18.12.3 REVENUE ANALYSIS
18.12.4 PRODUCT PORTFOLIO
18.12.5 RECENT DEVELOPEMENTS
18.13 VWR INTERNATIONAL, LLC
18.13.1 COMPANY OVERVIEW
18.13.2 GEOGRAPHIC PRESENCE
18.13.3 REVENUE ANALYSIS
18.13.4 PRODUCT PORTFOLIO
18.13.5 RECENT DEVELOPEMENTS
18.14 MOCARE HEALTH CO., LTD.
18.14.1 COMPANY OVERVIEW
18.14.2 GEOGRAPHIC PRESENCE
18.14.3 REVENUE ANALYSIS
18.14.4 PRODUCT PORTFOLIO
18.14.5 RECENT DEVELOPEMENTS
18.15 4S HBM LTD
18.15.1 COMPANY OVERVIEW
18.15.2 GEOGRAPHIC PRESENCE
18.15.3 REVENUE ANALYSIS
18.15.4 PRODUCT PORTFOLIO
18.15.5 RECENT DEVELOPEMENTS
18.16 SHANGHAI HBM HEALTHCARES. INC
18.16.1 COMPANY OVERVIEW
18.16.2 GEOGRAPHIC PRESENCE
18.16.3 REVENUE ANALYSIS
18.16.4 PRODUCT PORTFOLIO
18.16.5 RECENT DEVELOPEMENTS
18.17 MOTEX HEALTHCARE CORP.
18.17.1 COMPANY OVERVIEW
18.17.2 GEOGRAPHIC PRESENCE
18.17.3 REVENUE ANALYSIS
18.17.4 PRODUCT PORTFOLIO
18.17.5 RECENT DEVELOPEMENTS
18.18 TG MEDICAL SDN BHD
18.18.1 COMPANY OVERVIEW
18.18.2 GEOGRAPHIC PRESENCE
18.18.3 REVENUE ANALYSIS
18.18.4 PRODUCT PORTFOLIO
18.18.5 RECENT DEVELOPEMENTS
18.19 B. BRAUN MELSUNGEN AG
18.19.1 COMPANY OVERVIEW
18.19.2 GEOGRAPHIC PRESENCE
18.19.3 REVENUE ANALYSIS
18.19.4 PRODUCT PORTFOLIO
18.19.5 RECENT DEVELOPEMENTS
18.2 HUTCHINSON GLOVES
18.20.1 COMPANY OVERVIEW
18.20.2 GEOGRAPHIC PRESENCE
18.20.3 REVENUE ANALYSIS
18.20.4 PRODUCT PORTFOLIO
18.20.5 RECENT DEVELOPEMENTS
18.21 MUN GLOBAL
18.21.1 COMPANY OVERVIEW
18.21.2 GEOGRAPHIC PRESENCE
18.21.3 REVENUE ANALYSIS
18.21.4 PRODUCT PORTFOLIO
18.21.5 RECENT DEVELOPEMENTS
18.22 GUILIN HBM HEALTH PROTECTIONS,INC.
18.22.1 COMPANY OVERVIEW
18.22.2 GEOGRAPHIC PRESENCE
18.22.3 REVENUE ANALYSIS
18.22.4 PRODUCT PORTFOLIO
18.22.5 RECENT DEVELOPEMENTS
18.23 S2S GLOBAL
18.23.1 COMPANY OVERVIEW
18.23.2 GEOGRAPHIC PRESENCE
18.23.3 REVENUE ANALYSIS
18.23.4 PRODUCT PORTFOLIO
18.23.5 RECENT DEVELOPEMENTS
18.24 MEDICSHELF
18.24.1 COMPANY OVERVIEW
18.24.2 GEOGRAPHIC PRESENCE
18.24.3 REVENUE ANALYSIS
18.24.4 PRODUCT PORTFOLIO
18.24.5 RECENT DEVELOPEMENTS
18.25 INNOVATIVE HEALTH CARE
18.25.1 COMPANY OVERVIEW
18.25.2 GEOGRAPHIC PRESENCE
18.25.3 REVENUE ANALYSIS
18.25.4 PRODUCT PORTFOLIO
NOTE: THE COMPANIES PROFILED IS NOT EXHAUSTIVE LIST AND IS AS PER OUR PREVIOUS CLIENT REQUIREMENT. WE PROFILE MORE THAN 100 COMPANIES IN OUR STUDY AND HENCE THE LIST OF COMPANIES CAN BE MODIFIED OR REPLACED ON REQUEST
19 RELATED REPORTS
20 CONCLUSION
21 QUESTIONNAIRE
22 ABOUT DATA BRIDGE MARKET RESEARCH
